Checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?

被引：2
|
作者：
Balzarotti, Monica [1 ]
Santoro, Armando [1 ]
机构：
[1] Humanitas Canc Ctr, Rozzano, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 16期
关键词：
BRENTUXIMAB VEDOTIN; TRANSPLANTATION; CHEMOTHERAPY; MULTICENTER; EXPRESSION; INDUCTION; SCLEROSIS; CHOP;
D O I：
10.21037/atm.2020.04.06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Rituximab Combined With MACOP-B or VACOP-B and Radiation Therapy in Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study
    Zinzani, Pier Luigi
    Stefoni, Vittorio
    Finolezzi, Erica
    Brusamolino, Ercole
    Cabras, Maria Giuseppina
    Chiappella, Annalisa
    Salvi, Flavia
    Rossi, Andrea
    Broccoli, Alessandro
    Martelli, Maurizio
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (05) : 381 - 385
  • [32] Defining primary refractory large B-cell lymphoma
    Bock, Allison M.
    Mwangi, Raphael
    Wang, Yucai
    Khurana, Arushi
    Maurer, Matthew J.
    Ayers, Amy
    Kahl, Brad S.
    Martin, Peter
    Cohen, Jonathon B.
    Casulo, Carla
    Lossos, Izidore S.
    Farooq, Umar
    Ayyappan, Sabarish
    Reicks, Tanner
    Habermann, Thomas M.
    Witzig, Thomas E.
    Flowers, Christopher R.
    Cerhan, James R.
    Nastoupil, Loretta J.
    Nowakowski, Grzegorz S.
    BLOOD ADVANCES, 2024, 8 (13) : 3402 - 3415
  • [33] Treatment strategies and survival outcomes of primary mediastinal large B-cell lymphoma
    Quan, Lin
    He, Zhen
    Zuo, Xiaoling
    Cao, Lei
    Wang, Yi
    Dai, Hongyu
    Wu, Wei
    Shi, Xiao
    Liu, Hailing
    HEMATOLOGY, 2023, 28 (01)
  • [34] The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients
    Broccoli, Alessandro
    Casadei, Beatrice
    Stefoni, Vittorio
    Pellegrini, Cinzia
    Quirini, Federica
    Tonialini, Lorenzo
    Morigi, Alice
    Marangon, Miriam
    Argnani, Lisa
    Zinzani, Pier Luigi
    BMC CANCER, 2017, 17
  • [35] Nivolumab for CNS relapsed refractory primary mediastinal B-cell lymphoma: case report and review of the literature
    Shaulov, Adir
    Even-Zohar, Noa Gross
    Aumann, Shlomzion
    Haran, Arnon
    Linetsky, Eduard
    LEUKEMIA & LYMPHOMA, 2024, 65 (14) : 2219 - 2223
  • [36] Racial patterns of patients with primary mediastinal large B-cell lymphoma SEER analysis
    Liu, Pan-Pan
    Wang, Ke-Feng
    Xia, Yi
    Bi, Xi-Wen
    Sun, Peng
    Wang, Yu
    Li, Zhi-Ming
    Jiang, Wen-Qi
    MEDICINE, 2016, 95 (27)
  • [37] Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma
    Lekovic, Danijela
    Miljic, Predrag
    Mihaljevic, Biljana
    THROMBOSIS RESEARCH, 2010, 126 (06) : 477 - 480
  • [38] Primary mediastinal large B-cell lymphoma from the clinic to genomics: Insights for pathologists
    Fakhruddin, Najla
    Abou Dalle, Iman
    Chakhachiro, Zaher
    HUMAN PATHOLOGY, 2025, 156
  • [39] Primary mediastinal large B-cell lymphoma that occurs in an unexpected localization
    Inceman, Merve
    Pehlivan, Umur Anil
    Toyran, Tugba
    Ozdek, Recep
    Paydas, Semra
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (01): : 304 - 305
  • [40] Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do?
    Grant, Cliona
    Dunleavy, Kieron
    Eberle, Franziska C.
    Pittaluga, Stefania
    Wilson, Wyndham H.
    Jaffe, Elaine S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (03) : 157 - 163
12345